Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Sept 2026 for Eikon Therapeutics, Inc., €889k.
Filing timeline
BuySaleColumn Group IV GP, LP
Insider track record
Disclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Column Group IV GP, LP: trading record in brief
This profile gathers the share dealings of Column Group IV GP, LP in Eikon Therapeutics, Inc. We count 11 filings; the first trade dates from 6 February 2026 and the latest from 3 September 2026.
No open-market sale appears; the market trades are 4 purchases worth €33.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The median purchase comes to €5.3M. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 8 September 2026, reports an open-market purchase of €889k in Eikon Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Column Group IV GP, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
89,200 shares@ US$11.5588Common StockSEC:0001193125-26-385268:0
Canonical exit: 2 Dec 2026 (T+90)
1,296,629 sharesCommon StockSEC:0001193125-26-043320:0
2 of 2 declarations
